ATE512988T1 - Antikörper gegen epcam und anwendungen davon - Google Patents

Antikörper gegen epcam und anwendungen davon

Info

Publication number
ATE512988T1
ATE512988T1 AT08759374T AT08759374T ATE512988T1 AT E512988 T1 ATE512988 T1 AT E512988T1 AT 08759374 T AT08759374 T AT 08759374T AT 08759374 T AT08759374 T AT 08759374T AT E512988 T1 ATE512988 T1 AT E512988T1
Authority
AT
Austria
Prior art keywords
epcam
antibodies
therapeutic
designated
high affinity
Prior art date
Application number
AT08759374T
Other languages
English (en)
Inventor
Anna Maria Anastasi
Fiorella Petronzelli
Santis Rita De
Saverio Alberti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE512988T1 publication Critical patent/ATE512988T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT08759374T 2007-04-04 2008-04-02 Antikörper gegen epcam und anwendungen davon ATE512988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105628 2007-04-04
PCT/EP2008/053913 WO2008122551A2 (en) 2007-04-04 2008-04-02 Anti-epcam antibody and uses thereof

Publications (1)

Publication Number Publication Date
ATE512988T1 true ATE512988T1 (de) 2011-07-15

Family

ID=38458122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759374T ATE512988T1 (de) 2007-04-04 2008-04-02 Antikörper gegen epcam und anwendungen davon

Country Status (21)

Country Link
US (1) US8318911B2 (de)
EP (1) EP2142570B1 (de)
JP (1) JP5631733B2 (de)
KR (1) KR101683884B1 (de)
CN (1) CN101970497B (de)
AT (1) ATE512988T1 (de)
AU (1) AU2008235566B2 (de)
BR (1) BRPI0810096A8 (de)
CA (1) CA2682296C (de)
CY (1) CY1111819T1 (de)
DK (1) DK2142570T3 (de)
EA (1) EA023679B1 (de)
ES (1) ES2367675T3 (de)
HR (1) HRP20110620T1 (de)
IL (1) IL201196A0 (de)
MX (1) MX2009010444A (de)
PL (1) PL2142570T3 (de)
PT (1) PT2142570E (de)
RS (1) RS52040B (de)
SI (1) SI2142570T1 (de)
WO (1) WO2008122551A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169516B2 (en) 2003-01-24 2015-10-27 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
AU2009329987B2 (en) 2008-12-22 2016-08-04 University Of Utah Research Foundation Monochrome multiplex quantitative PCR
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
WO2012123755A1 (en) 2011-03-17 2012-09-20 The University Of Birmingham Re-directed immunotherapy
WO2013003624A2 (en) * 2011-06-29 2013-01-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
JP6163502B2 (ja) * 2012-03-02 2017-07-12 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 抗上皮細胞接着分子（ＥｐＣＡＭ）抗体及びその使用方法
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
CN105283559A (zh) 2013-05-22 2016-01-27 端粒诊断公司 短端粒丰度的量度
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
EP3328897A1 (de) 2015-07-31 2018-06-06 Sutro Biopharma, Inc. Anti-epcam-antikörper, zusammensetzungen mit anti-epcam-antikörpern und verfahren zur herstellung und verwendung von anti-epcam-antikörpern
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
WO2017173091A1 (en) * 2016-03-30 2017-10-05 Musc Foundation For Research Development Methods for treatment and diagnosis of cancer by targeting glycoprotein a repetitions predominant (garp) and for providing effective immunotherapy alone or in combination
CA3031846A1 (en) 2016-07-26 2018-02-01 Tessa Therapeutics Pte. Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
AU2019402097A1 (en) 2018-12-17 2021-06-10 Revitope Limited Twin immune cell engager
WO2020216210A1 (zh) * 2019-04-22 2020-10-29 江苏恒瑞医药股份有限公司 抗EpCAM抗体及其应用
CN114026127B (zh) * 2019-06-11 2024-10-29 生物蛋白有限公司 条件活性抗epcam抗体、抗体片段、其免疫缀合物以及其用途
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体
CN113527491B (zh) 2020-08-19 2023-06-20 苏州易慕峰生物科技有限公司 人源化抗体、嵌合抗原受体、核酸、载体、细胞及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) * 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5525338A (en) 1992-08-21 1996-06-11 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin conjugates
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
JP3427871B2 (ja) * 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
ITRM20010079A1 (it) 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
US7435804B2 (en) 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b

Also Published As

Publication number Publication date
WO2008122551A3 (en) 2008-12-04
EA023679B1 (ru) 2016-06-30
CA2682296C (en) 2017-02-28
WO2008122551A9 (en) 2009-02-05
SI2142570T1 (sl) 2012-01-31
CA2682296A1 (en) 2008-10-16
PL2142570T3 (pl) 2011-11-30
ES2367675T3 (es) 2011-11-07
IL201196A0 (en) 2010-05-17
BRPI0810096A8 (pt) 2017-12-26
DK2142570T3 (da) 2011-10-03
WO2008122551A2 (en) 2008-10-16
US8318911B2 (en) 2012-11-27
KR20100016237A (ko) 2010-02-12
EA200970923A1 (ru) 2010-04-30
US20100092491A1 (en) 2010-04-15
JP2010523096A (ja) 2010-07-15
BRPI0810096A2 (pt) 2014-10-21
CN101970497B (zh) 2017-05-10
AU2008235566B2 (en) 2013-06-06
CN101970497A (zh) 2011-02-09
PT2142570E (pt) 2011-09-13
RS52040B (en) 2012-04-30
KR101683884B1 (ko) 2016-12-07
HRP20110620T1 (hr) 2011-09-30
MX2009010444A (es) 2009-10-20
JP5631733B2 (ja) 2014-11-26
AU2008235566A1 (en) 2008-10-16
EP2142570A2 (de) 2010-01-13
EP2142570B1 (de) 2011-06-15
CY1111819T1 (el) 2015-10-07

Similar Documents

Publication Publication Date Title
ATE512988T1 (de) Antikörper gegen epcam und anwendungen davon
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
CY1120398T1 (el) Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη
EA200970210A1 (ru) Prlr-специфическое антитело и его применения
UA113712C2 (xx) Антитіло до fap і способи його застосування
EA201171060A1 (ru) Молекулы антител, обладающих специфичностью к человеческому ох40
NZ602256A (en) Monoclonal antibodies against the rgm a protein and uses thereof
CY1117236T1 (el) Μονοκλωνικα αντισωματα εναντι γλυπικανης-3
EA201390933A1 (ru) Антитела против мезотелина и иммуноконъюгаты
EA201070695A1 (ru) Молекулы гуманизированных антител, специфичных к il-31
PE20140232A1 (es) Proteinas de enlace antigeno capaz de enlazar linfopoyetina estromal timica
EA200900492A1 (ru) Молекулы антител, которые связываются с il-17a и il-17f
GT201200271A (es) Proteínas que se unen al tnf-a
EA201300978A1 (ru) Антитела к сеа
CU20120095A7 (es) Antagonistas de pcsk9
EP2542581A4 (de) Apolipoproteinspezifischer antikörper und anwendungsverfahren dafür
NO20085362L (no) Hoyaffinitets humane og humaniserte anti-alfa5 beta1-integrin funksjonsblokkerende antistoffer med redusert immunogenisitet
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
MX2021000392A (es) Anticuerpos anti-mesotelina.
EA201291180A1 (ru) Композиции и способы применения терапевтических антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
EA201791691A1 (ru) ОДНОДОМЕННЫЕ АНТИТЕЛА, НАПРАВЛЕННЫЕ НА CD1d
WO2017015634A3 (en) Constructs targeting psa peptide/mhc complexes and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2142570

Country of ref document: EP